Madrigal Pharmaceuticals (MDGL) Inventory (2024 - 2026)

Madrigal Pharmaceuticals (MDGL) has reported Inventory for 3 consecutive years, with $99.4 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Inventory rose 56.53% year-over-year to $99.4 million; the TTM figure through Jun 2026 stood at $99.4 million (up 56.53% YoY), while the FY2025 annual figure was $74.8 million, up 119.68% from the prior year.
• Inventory eased to $99.4 million in Q2 2026 per MDGL's latest filing, from $112.1 million in the prior quarter.
• Across five years, Inventory topped out at $112.1 million in Q1 2026 and bottomed at $854000.0 in Q1 2024.
• Historically, Inventory has averaged $52.5 million across 3 years, with a median of $59.4 million in 2025.
• Annual changes were most pronounced in 2025 — Inventory surged 6368.5% — and 2026, when it surged 56.53%.
• Madrigal Pharmaceuticals' Inventory stood at $34.1 million in 2024, then jumped by 119.68% to $74.8 million in 2025, then surged by 32.8% to $99.4 million in 2026.
• Business Quant data shows MDGL's Inventory at $99.4 million in Q2 2026, $112.1 million in Q1 2026, and $74.8 million in Q4 2025.